Home > Insider Trading > Filing (0001209191-21-008888)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1817229	Vor Biopharma Inc.	VOR	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1664281	Kush Parmar	C/O Vor Biopharma Inc. 100 Cambridgepark Drive, Suite 400 Cambridge MA 02140		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-02-09	3,308,822	$0.00	3,308,822	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2021-02-09	1,414,026	$0.00	4,722,848	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2021-02-09	111,111	$18.00	4,833,959	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2021-02-09	1,414,026	$0.00	1,414,026	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2021-02-09	444,444	$18.00	1,858,470	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2021-02-05	16,900	$0.00	16,900	$18.00
Common Stock	Series A-2 Preferred Stock	Disposition	2021-02-09	45,000,000	$0.00	3,308,822	$0.00
Common Stock	Series B Preferred Stock	Disposition	2021-02-09	19,230,768	$0.00	1,414,026	$0.00
Common Stock	Series B Preferred Stock	Disposition	2021-02-09	19,230,768	$0.00	1,414,026	$0.00

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
16,900	2031-02-04	No	4	A	Direct
0		No	4	C	Indirect
0		No	4	C	Indirect
0		No	4	C	Indirect

Footnotes

Each share of Series A-2 Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock upon the closing ofthe Issuer's initial public offering for no additional consideration, on a 13.6 for-one basis, and had no expiration date.
The shares are directly held by 5AM Ventures VI, L.P. 5AM Partners VI, LLC is the general partner of 5AM Ventures VI, L.P. The ReportingPerson is a managing member of 5AM Partners VI, LLC, and may be deemed to share voting and dispositive power over the shares held by 5AMVentures VI, L.P. The reporting person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interesttherein.
The shares are directly held by 5AM Opportunities I, L.P. 5AM Opportunities I (GP), LLC is the general partner of 5AM Opportunities I, L.P. TheReporting Person is a managing member of 5AM Opportunities I (GP), LLC, and may be deemed to share voting and dispositive power over theshares held by 5AM Opportunities I, L.P. The reporting person disclaims beneficial ownership of the reported securities, except to the extent ofhis pecuniary interest therein.
1/36th of the shares underlying the option vest in equal monthly installments commencing on March 5, 2021, provided that the Reporting Person remains continuously engaged by the Issuer on each such vesting date.